Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee.

NCT03988023 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
1043
Enrollment
INDUSTRY
Sponsor class

Stopped The AP-013 study was prematurely terminated by the sponsor after Data Safety Monitoring Board (DSMB) guidance.

Conditions

Interventions

Sponsor

Ampio Pharmaceuticals. Inc.